|
BCRX
|
BioCryst Pharmaceuticals, Inc.
|
0.58%
|
US
|
NASDAQ
|
|
KRYS
|
Krystal Biotech, Inc.
|
0.57%
|
US
|
NASDAQ
|
|
GKOS
|
Glaukos Corporation
|
0.57%
|
US
|
NYSE
|
|
ATRC
|
AtriCure, Inc.
|
0.57%
|
US
|
NASDAQ
|
|
CLDX
|
Celldex Therapeutics, Inc.
|
0.56%
|
US
|
NASDAQ
|
|
AKRO
|
Akero Therapeutics, Inc.
|
0.56%
|
US
|
NASDAQ
|
|
RVMD
|
Revolution Medicines, Inc.
|
0.53%
|
US
|
NASDAQ
|
|
SILK
|
Silk Road Medical, Inc.
|
0.52%
|
US
|
NASDAQ
|
|
PACB
|
Pacific Biosciences of California, Inc.
|
0.51%
|
US
|
NASDAQ
|
|
FGEN
|
FibroGen, Inc
|
0.50%
|
US
|
NASDAQ
|
|
ARVN
|
Arvinas, Inc.
|
0.48%
|
US
|
NASDAQ
|
|
SWTX
|
SpringWorks Therapeutics, Inc.
|
0.47%
|
US
|
NASDAQ
|
|
VCYT
|
Veracyte, Inc.
|
0.45%
|
US
|
NASDAQ
|
|
TGTX
|
TG Therapeutics, Inc.
|
0.45%
|
US
|
NASDAQ
|
|
XNCR
|
Xencor, Inc.
|
0.44%
|
US
|
NASDAQ
|
|
AGIO
|
Agios Pharmaceuticals, Inc.
|
0.44%
|
US
|
NASDAQ
|
|
FNA
|
Paragon 28, Inc.
|
0.43%
|
US
|
NYSE
|
|
DCPH
|
Deciphera Pharmaceuticals, Inc.
|
0.40%
|
US
|
NASDAQ
|
|
TWST
|
Twist Bioscience Corporation
|
0.39%
|
US
|
NASDAQ
|
|
RVNC
|
Revance Therapeutics, Inc.
|
0.39%
|
US
|
NASDAQ
|